Synthesis of3H- and2H4-labelled versions of the hypoxia-activated pre-prodrug 2-[(2-bromoethyl)-2,4-dinitro-6- [[[2-(phosphonooxy)ethyl]amino]carbonyl]anilino]ethyl methanesulfonate (PR-104)-Reference-Cited by-同舟云学术

Synthesis of3H- and2H4-labelled versions of the hypoxia-activated pre-prodrug 2-[(2-bromoethyl)-2,4-dinitro-6- [[[2-(phosphonooxy)ethyl]amino]carbonyl]anilino]ethyl methanesulfonate (PR-104)

Published:2007 Issue:1 Volume:50 Page:7-12
ISSN:0362-4803
Container-title:Journal of Labelled Compounds and Radiopharmaceuticals
language:en
Short-container-title:J Label Compd Radiopharm

Author:

Atwell Graham J.,Denny William A.

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

Reference5 articles.

1. , , , , . PCT Int Appl WO 2005042471 A1 (85 pp), published 12th May 2005.

2. Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5-[ N , N -bis(2-chloroethyl)amino]-2,4-dinitrobenzamide (SN 23862) and the corresponding aziridine (CB 1954) in KHT tumour-bearing mice

3. Synthesis and Anaphylactogenicity of Monohaptenic Carbohydrate Conjugates

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporation of Hydrogen Isotopes into Biologically Active Compounds;Radiochemistry;2022-08

2. Interrogation of the Structure–Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications;Pharmaceuticals;2022-02-01

3. Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3;Pharmaceuticals;2021-11-26

4. Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506;Molecular Cancer Therapeutics;2021-10-08

5. Apoptotic body–mediated intercellular delivery for enhanced drug penetration and whole tumor destruction;Science Advances;2021-04-16